Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.48 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.48 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.48 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.48 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.48 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.48 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2797428 | 0.89 | TDP1 (0.60) | L3MBTL1TDP1MAPTLMNANR4A2 | |
| SCHEMBL25413887 | 0.87 | TDP1 (0.63) | L3MBTL1TDP1MAPTLMNANR4A2 | |
| SCHEMBL7716363 | 0.84 | TDP1 (0.57) | L3MBTL1TDP1MAPTLMNANR4A2 | |
| SCHEMBL7716366 | 0.84 | TDP1 (0.57) | L3MBTL1TDP1MAPTLMNANR4A2 | |
| SCHEMBL27687045 | 0.82 | MAPT (0.58) | L3MBTL1TDP1MAPTLMNANR4A2 | |
| SCHEMBL6935004 | 0.82 | TDP1 (0.68) | L3MBTL1TDP1MAPTLMNANR4A2 | |
| SCHEMBL2749745 | 0.81 | NPC1 (0.58) | MAPTLMNAKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL5708597 | 0.81 | ALDH1A1 (0.47) | TDP1MAPTLMNAKMT2AALDH1A1 | |
| SCHEMBL28689137 | 0.81 | L3MBTL1 (0.50) | L3MBTL1TDP1MAPTLMNANR4A2 | |
| SCHEMBL7145858 | 0.81 | MAPT (0.45) | L3MBTL1MAPTKMT2AALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114059114-B | Cyanide-free low-temperature black tin-nickel alloy electroplating solution and electroplating process | 厦门华弘昌科技有限公司 | 2023-02-10 | — | — | CN | claimed |
| CN-114059114-A | Cyanide-free low-temperature black tin-nickel alloy electroplating solution and electroplating process | 厦门华弘昌科技有限公司 | 2022-02-18 | — | — | CN | claimed |
| CN-111542736-B | Temperature detecting material and estimation system for temperature deviation time using the same | 株式会社日立产机系统 | 2023-08-29 | — | — | CN | disclosed |
| CN-114950558-B | Bipiperidine skeleton tetradentate nitrogen-containing manganese catalyst and method for catalyzing hydrocarbon molecule benzyl site selective oxidation by using same | 陕西师范大学 | 2023-08-11 | — | — | CN | disclosed |
| CN-115436510-A | Method for identifying difference of flavor compounds in livestock and poultry meat based on gas chromatography-electrostatic field orbit trap high-resolution mass spectrometry | 中国农业科学院北京畜牧兽医研究所 | 2022-12-06 | — | — | CN | disclosed |
| CN-114950558-A | Bipiperidine skeleton tetradentate nitrogen-containing manganese catalyst and method for catalyzing benzyl-site selective oxidation of hydrocarbon molecules by using same | 陕西师范大学 | 2022-08-30 | — | — | CN | disclosed |
| CN-114933543-A | Synthetic method of 3-cyclopropylamino-2- (2, 4-dichloro-5-fluorobenzoyl) methyl acrylate | 山东国邦药业有限公司 | 2022-08-23 | — | — | CN | disclosed |
| CN-110678170-A | Pullulan polysaccharide capsule | 比利时胶囊公司 | 2020-01-10 | — | — | CN | disclosed |
| US-10253205-B2 | Aqueous composition for forming a hardcoat layer and hardcoat layer | FUJIFILM CORPORATION (JP) | 2019-04-09 | — | — | US | disclosed |
| US-20160017173-A1 | AQUEOUS COMPOSITION FOR FORMING A HARDCOAT LAYER AND HARDCOAT LAYER | FUJIFILM CORPORATION (JP) | 2016-01-21 | — | — | US | disclosed |
| US-9223211-B2 | Photosensitive resin compositions, processes for preparing cured films, the resulting cured films, organic EL display devices and liquid crystal display devices | FUJIFILM CORPORATION (JP) | 2015-12-29 | — | — | US | disclosed |
| WO-2006122788-A1 | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR | LABORATORIOS ALMIRALL, S.A. (ES) | 2006-11-23 | — | — | WO | disclosed |
| US-20050014942-A1 | Transforming growth factor inhibitor; controllign cell differentiation, cell proliferation | NIPPON SHINYAKU CO., LTD. (JP) | 2005-01-20 | — | — | US | disclosed |
| EP-1452525-A1 | AMIDE DERIVATIVES AND DRUGS | Nippon Shinyaku Co., Ltd. (JP) | 2004-09-01 | — | — | EP | disclosed |
| US-5670563-A | ORGANOTIN COMPOUND, PHOSPHORUS COMPOUND | CIBA-SPECIALTY CHEMICALS CORPORATION (US) | 1997-09-23 | — | — | US | disclosed |
| EP-0542300-B1 | Method of preparing (S)-1-phenyl-1,3-propanediol or derivatives thereof | AJINOMOTO KK (JP) | 1997-02-26 | — | — | EP | disclosed |
| US-5393664-A | Using a culture product | AJINOMOTO CO. INC. (JP) | 1995-02-28 | — | — | US | disclosed |
| EP-0542300-A2 | Method of preparing (S)-1-phenyl-1,3-propanediol or derivatives thereof | Ajinomoto Co., Inc. (JP) | 1993-05-19 | — | — | EP | disclosed |
| US-4958021-A | PRESSURE AND HEAT SENSITIVE RECORDING MATERIALS | BASF AKTIENGESELLSCHAFT (DE) | 1990-09-18 | — | — | US | disclosed |
| US-4022773-A | 7-ACYLAMINO-3-SUBSTITUTED-3-CEPHEM-4-CARBOXYLIC ACIDS, 1-OXIDES | ISHIMARU TOSHIYASU | 1977-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014942-A1 | Transforming growth factor inhibitor; controllign cell differentiation, cell proliferation | TGFBR1, TGFBR2, TGFB1 | L3MBTL1 1514/4885TDP1 4752/4885MAPT 4750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.